Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer

PURPOSE: Prescribing NAC for breast cancer is a pragmatic treatment strategy for several reasons; however, certain patients suffer chemotherapy-induced toxicities. Unfortunately, identifying patients at risk of toxicity often proves challenging. MiRNAs are small non-coding RNA molecules which modula...

Descripción completa

Detalles Bibliográficos
Autores principales: Davey, Matthew G., Abbas, Ray, Kerin, Eoin P., Casey, Maire Caitlin, McGuire, Andrew, Waldron, Ronan M., Heneghan, Helen M., Newell, John, McDermott, Ailbhe M., Keane, Maccon M., Lowery, Aoife J., Miller, Nicola, Kerin, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504160/
https://www.ncbi.nlm.nih.gov/pubmed/37540289
http://dx.doi.org/10.1007/s10549-023-07033-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504160/
https://www.ncbi.nlm.nih.gov/pubmed/37540289
http://dx.doi.org/10.1007/s10549-023-07033-8

Ejemplares similares